XBiotech Inc (NASDAQ:XBIT)
| 4.13 Delayed Data As of Sep 27 |  -0.14 / -3.37%Today’s Change | 3.00 Today|||52-Week Range 6.69 | +17.66% Year-to-Date |
Latest XBIT News | Press Releases
No recent news for XBiotech Inc.
Today’s Trading
| Previous close | 4.16 |
| Today’s open | 4.02 |
| Day’s range | 4.02 - 4.27 |
| Volume | 28,672 |
| Average volume (3 months) | 45,191 |
| Market cap | $165.9M |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | -86.47% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -78.20% |
| P/E ratio | NM |
| Price/Sales | 26.64 |
| Price/Book | 0.57 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PLXProtalix Biotherapeu... | +0.06 | +3.66% |
| INMBINmune Bio Inc | +0.01 | +0.14% |
| ---- | ||
| ---- |
Data as of 3:59pm ET, 09/27/2023
Financials
| Last reporting date | May 13, 2020 |
| EPS forecast (this quarter) | $0.06 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$32.9M |
| Net profit margin | -820.45% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Austin, Texas |
Forecasts
